Related Experiment Video
Updated: Aug 12, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Inhibition of Na+ channels by the novel blocker PD85,639
D S Ragsdale1, R Numann, W A Catterall
1Department of Pharmacology, University of Washington, Seattle 98195.
Abstract:
This study examined the actions of the novel Na+ channel blocker PD85,639. In whole-cell voltage-clamp recordings from Chinese hamster ovary cells transfected with a cDNA encoding the rat brain type IIA Na+ channel and from dissociated rat brain neurons, PD85,639 attenuated Na+ currents when applied either in the external bath or in the internal pipette solution. Block had a tonic component that occurred in the absence of stimulus pulses and an additional use-dependent component that developed during a train of pulses. The EC50 for tonic block was 30 microM and was not strongly dependent on the holding potential. Use-dependent block was first detectable at 1 microM and was pronounced at higher concentrations, even at stimulus frequencies as low as 1 pulse/2 min. The marked use-dependent block was due to rapid drug binding during depolarizing pulses and very slow recovery of drug-bound channels between the pulses (tau = 11 min at -85 mV). Use-dependent block was greater at more depolarized potentials, suggesting that the drug binding site was partway across the membrane electric field. The block that developed with strong depolarizations was rapidly reversed by opening channels with trains of unblocking pulses to more negative potentials. These characteristics of block by PD85,639 suggest that it is a local anesthetic drug with novel properties.
More Related Videos
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...